Phase 1b/2a in SLE With Budoputug

NCT06570434 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was never initiated

Conditions

Systemic Lupus Erythematosus
SLE
B Cells

Interventions

DRUG: budoprutug

Sponsor

Tenet Medicines